EcoDrugPlus

Ensembl ID : ENSSAUG00010000511
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSSAUG00010002792
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSSAUG00010003853
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSSAUG00010003830
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSSAUG00010017437
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSSAUG00010024452
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSSAUG00010002022
Gene Symbol: -
Cross references: -
382 Possible Orthologues:

Ensembl ID : ENSSAUG00010002010
Gene Symbol: -
Cross references: -
354 Possible Orthologues:

Ensembl ID : ENSSAUG00010002031
Gene Symbol: -
Cross references: -
378 Possible Orthologues:

Ensembl ID : ENSSAUG00010002255
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSSAUG00010002035
Gene Symbol: -
Cross references: -
378 Possible Orthologues:

Ensembl ID : ENSSAUG00010000593
Gene Symbol: -
Cross references: -
236 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).